Clinical trial
A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on…
NCT00261677 · Ortho Biotech Products, L.P., Industry · Completed
Key facts
| NCT number | NCT00261677 |
|---|---|
| Title | A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) on Anemia and Quality of Life in Children With Cancer Undergoing Myelosuppressive Chemotherapy |
| Lead sponsor | Ortho Biotech Products, L.P., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Hodgkin Disease, Leukemia, Lymphoma, Non-hodgkin |
| Intervention type | Drug |
| Interventions | epoetin alfa |
| Enrollment | 224 |
| Start date | Aug 1, 2000 |
| Completion | Oct 1, 2003 |
| First posted | Dec 5, 2005 |
| Last update posted | May 23, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: